Vera Therapeutics, Inc

Nkarta, Inc. is a South San Francisco-based biotechnology company dedicated to harnessing the potential of natural killer (NK) cells for the treatment of cancer. With a focus on developing next-generation cell therapies, Nkarta's proprietary technology aims to enhance the power, applicability, and tolerability of cell therapy by leveraging the inherent pathogen-fighting abilities of NK cells. Founded on the robust and well-characterized NK cell expansion technology pioneered by Dario Campana, Nkarta is committed to building the next generation of cell therapies that have the potential to reach more patients. As a young and innovative company, Nkarta embraces diversity and seeks to bring innovation to patients with cancer through its dynamic perspective and intense purpose.Generated from the website

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies aimed at improving the treatment of immune diseases and cancer. Their lead program, soquelitinib, is a first-in-class oral therapy designed to selectively inhibit ITK, thereby modulating and controlling key signaling pathways within the immune system. Committed to advancing scientific knowledge and patient care, Corvus embraces a culture that fosters leadership, collaboration, and innovation. The company is actively expanding its pipeline while engaging with investors and stakeholders to drive progress in therapeutic development. Generated from the website